First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
Sign Up to like & getrecommendations! Published in 2021 at "Nature Medicine"
DOI: 10.1038/s41591-021-01408-4
Abstract: Reports of ChAdOx1 vaccine–associated thrombocytopenia and vascular adverse events have led to some countries restricting its use. Using a national prospective cohort, we estimated associations between exposure to first-dose ChAdOx1 or BNT162b2 vaccination and hematological… read more here.
Keywords: first dose; chadox1; thromboembolic hemorrhagic; dose chadox1 ... See more keywords
A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters
Sign Up to like & getrecommendations! Published in 2019 at "PLoS Neglected Tropical Diseases"
DOI: 10.1371/journal.pntd.0007462
Abstract: Nipah virus (NiV) is a highly pathogenic re-emerging virus that causes outbreaks in South East Asia. Currently, no approved and licensed vaccine or antivirals exist. Here, we investigated the efficacy of ChAdOx1 NiVB, a simian… read more here.
Keywords: protection; chadox1; chadox1 nivb; dose chadox1 ... See more keywords
Outcome after single dose of ChAdOx1 vaccine against SARS-CoV-2 infection at 16 weeks post-vaccination among healthy adults in Saudi Arabia
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Saudi Medicine"
DOI: 10.5144/0256-4947.2022.223
Abstract: BACKGROUND: The rate of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) infection and immunogenicity of a single dose of ChAdOx1 vaccine at 16 weeks post-vaccination among young and healthy participants remains unclear in Saudi… read more here.
Keywords: vaccination; infection; dose chadox1; post vaccination ... See more keywords